Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Value Of Small Biotech Model In Big Pharma Is Unproven – Former GSK Execs

This article was originally published in The Pink Sheet Daily

Executive Summary

GSK’s formation of the Centers of Excellence in Drug Discovery is an example of big pharma “pushing back” on inherent inefficiencies, but the “jury is still out” on large pharmaceutical companies imitating the biotech business model, former execs O’Bryan-Tear and Sorensen say.

You may also be interested in...

Novartis Unifies Oncology, Transplantation & Ophthalmics Under Epstein

Novartis' has unified oncology, transplantation and ophthalmics into one specialty medicine business unit as the company's product mix shifts more toward specialty care

Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal

A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability

McKindler? New Pfizer CEO Echoes McKinnell’s Views On Payers, Scale

Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts